Related references
Note: Only part of the references are listed.Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Ju Dong Yang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Hepatitis B Virus Load in Serum Does Not Reflect Histologic Activity in Patients With Decompensated Cirrhosis
Jin Dong Kim et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Factors That Determine the Development and Progression of Gastroesophageal Varices in Patients With Chronic Hepatitis C
Robert J. Fontana et al.
GASTROENTEROLOGY (2010)
Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C
Timothy R. Morgan et al.
HEPATOLOGY (2010)
Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
Ju Hyun Shim et al.
JOURNAL OF HEPATOLOGY (2010)
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Paul Y. Kwo et al.
LANCET (2010)
Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis
Kausik Das et al.
LIVER INTERNATIONAL (2010)
Telaprevir for Previously Treated Chronic HCV Infection.
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis
Ryota Masuzaki et al.
ONCOLOGY (2010)
Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study
Savino Bruno et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial
Mitchell L. Shiffman et al.
GASTROENTEROLOGY (2009)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Retreating Chronic Hepatitis C with Daily Interferon Alfacon-1/Ribavirin After Nonresponse to Pegylated Interferon/Ribavirin: DIRECT Results
Bruce R. Bacon et al.
HEPATOLOGY (2009)
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study
Jose A. Carrion et al.
JOURNAL OF HEPATOLOGY (2009)
Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension
E. G. Giannini et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure
Fabien Zoulim et al.
LIVER INTERNATIONAL (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis
G. T. Everson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis
Tomohiro Nishida et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C
T. -M. Scherzer et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Adrian M. Di Bisceglie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis
Bart J. Veldt et al.
ANNALS OF INTERNAL MEDICINE (2007)
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:: A randomized controlled trial
Vito Di Marco et al.
JOURNAL OF HEPATOLOGY (2007)
Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis
Erik H. C. J. Buster et al.
HEPATOLOGY (2007)
SCH 503034, a novel hepatitis C virus pro-tease inhibitor, plus pegylated interferon α-2b for genotype 1 nonresponders
Christoph Sarrazin et al.
GASTROENTEROLOGY (2007)
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results
Eugene Schiff et al.
LIVER TRANSPLANTATION (2007)
HCV-related advanced fibrosis/cirrhosis:: randomized controlled trial of pegylated interferon α-2a and ribavirin
Beat Helbling et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis
YF Liaw et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy
GT Everson et al.
HEPATOLOGY (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Infection with chronic hepatitis C virus and liver transplantation: A role for interferon therapy before transplantation
RM Thomas et al.
LIVER TRANSPLANTATION (2003)
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation
X Forns et al.
JOURNAL OF HEPATOLOGY (2003)
Report of the first international liver transplantation society expert panel consensus conference on liver transplantation and hepatitis C
RH Wiesner et al.
LIVER TRANSPLANTATION (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
RJ Fontana et al.
GASTROENTEROLOGY (2002)
A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation
JS Crippin et al.
LIVER TRANSPLANTATION (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis.
GV Papatheodoridis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis:: an evidence-based approach
C Cammà et al.
JOURNAL OF HEPATOLOGY (2001)
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
EJ Heathcote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
